drugset / Trial / NCT02262754
PF-06372865 In Subjects With Chronic Low Back Pain
RandomizedParallel-groupDouble-blindTreatment
Summary
PF-06372865 In Subjects With Chronic Low Back Pain
Timeline
- Start
- 2014-10
- Primary completion
- 2015-08
- Completion
- 2015-08
Outcome
Missed primary endpoint
registry analysis (superiority or other test); Placebo vs PF-06372865; Mean Difference (PF-06372865-Placebo) 0.16 (90% CI -0.28 to 0.60) NCT02262754 ↗
registry analysis (superiority or other test); Placebo vs PF-06372865; LS Mean Difference (PF-06372865-Placebo) -0.23 (90% CI -0.76 to 0.30) NCT02262754 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Darigabat | Small molecule | — | — |
| Comparator | Naproxen | Small molecule | 500 mg | — |